Current Gene Therapy

Papers
(The H4-Index of Current Gene Therapy is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Effective Combination of Single-cell Analysis and Gene Therapy47
A Comprehensive Review of Genetic Risk Factors for Alzheimer’s Disease Development33
Gene Augmentation Techniques to Stimulate Wound Healing Process: Progress and Prospects33
Next-Generation Whole-Exome Pattern: Advanced Methods and Clinical Significance32
Identifying ARRB2 as a Prognostic Biomarker and Key Player in the Tumor Microenvironment of Pancreatic Cancer through scPagwas Methodology28
Evaluation of the Cellular Effects of miR-30d-3p in A549 Cells Under Normoxic and Hypoxic Conditions26
Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation25
Synergizing CRISPR-Cas9 with Advanced Artificial Intelligence and Machine Learning for Precision Drug Delivery: Technological Nexus and Regulatory Insights25
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer23
Applications of L-Arginine in Pregnancy and Beyond: An Emerging Pharmacogenomic Approach22
Acknowledgements to Reviewers22
MDAlmc: A Novel Low-rank Matrix Completion Model for MiRNADisease Association Prediction by Integrating Similarities among MiRNAs and Diseases21
Identification and Validation of Amino Acid Metabolism-Related Biomarkers and Investigation of their Potential Mechanisms in Lung Adenocarcinoma21
DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer Vaccinations: Advancement and Developments21
Therapeutic Potential of POU3F3, a Novel Long Non-coding RNA, Alleviates the Pathogenesis of Osteoarthritis by Regulating the miR-29a- 3p/FOXO3 Axis21
Human Virus-Like Proteins: Implications for Gene Therapy20
Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal Cancer20
Harnessing Nanotechnology and Gene Editing for Cancer Therapy: ASynergistic Approach to Precision Medicine18
0.13276600837708